Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: Cyclosporine In Takotsubo Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating cyclosporine for Takotsubo cardiomyopathy is currently recruiting at University Hospital Heidelberg.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Takotsubo Cardiomyopathy | Phase 2 | Status: RECRUITING